Outcomes of Elderly (≥ 70) Acute Myeloid Leukemia (AML) Patients Receiving Continued Hypomethylating Agent/Venetoclax (HMA/VEN) Versus Allogeneic Hematopoietic Cell Transplantation (HCT)

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Onyee Chan, Reshma Ramlal, Syeda Mahrukh Naqvi, Jongphil Kim, Najla E. Al Ali, Fnu Amisha, David A. Sallman, Rawan G. Faramand, Farhad Khimani, Nancy Torres, Asmita Mishra, Abu-Sayeef Mirza
+9 more Eric Padron, Lia Elena Perez, Fabiana Perna, Alison Walker, Taiga Nishihori, Rami S. Komrokji, Joseph A. Pidala, Jeffrey E. Lancet, Nelli Bejanyan
DOI: 10.1016/j.jtct.2025.12.561
Cited by: 0

Fields of Study & Subjects

Acute Myeloid Leukemia Research Hematopoietic Stem Cell Transplantation Retinoids in leukemia and cellular processes

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S391–S391
Publication date
1 February 2026
Language
EN